Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.
about
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reductionTemporal validation of the UKPDS outcomes model using 10-year posttrial monitoring dataCirculating adiponectin and breast cancer risk: a systematic review and meta-analysis.Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats.Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortalityBurden of type 2 diabetes in Mexico: past, current and future prevalence and incidence ratesMacrovascular complication phenotypes in type 2 diabetic patients.Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policyAssociation between PPAR-γ2 Pro12Ala genotype and insulin resistance is modified by circulating lipids in Mexican childrenImpaired proteostasis: role in the pathogenesis of diabetes mellitus.Adiponectin-resistin index and its strong association with acute coronary syndrome in South Indian men.Cardioprotective role of Syzygium cumini against glucose-induced oxidative stress in H9C2 cardiac myocytes.Epidemiology of diabetes mellitus in Mexico.Pancreatic Elastase Levels in Feces As A Marker of Exocrine Pancreatic Function in Patients With Diabetes Mellitus.Metabolic effects of glycerol supplementation and aerobic physical training on Wistar rats.Diabetes Cultural Beliefs and Traditional Medicine Use Among Health Center Patients in Oaxaca, Mexico.Relationship between increased carotid artery stiffness and idiopathic subjective tinnitus: methodological issues.
P2860
Q21246041-A2D79C09-E4BA-4DB2-A071-215CB7D64EA7Q30583586-9E01D271-92AF-41C3-8844-4C444F0289EAQ34649283-00016528-F2F8-4E31-8B4F-E776ECC089CDQ35669260-9D0C831E-6935-4154-891A-4D387016A768Q36288833-C3D49E02-7376-415B-A43D-E53A21FCB158Q36373206-DD9F7F7B-D7D1-485F-8AA3-BBEFD0823E0CQ36572131-963421A4-8F6A-4E73-9F2E-0567681051E9Q36689221-578E3D2C-7A2C-4F38-BEF3-8CAE42B7FA2BQ36796281-11D4EFC2-0254-4866-BB4C-90776FDAE019Q38210860-4BFD6309-BB29-4EE9-8209-9DC55022B8D5Q39130111-43D0515A-FD3E-44BA-A872-17F35B0B072BQ39178300-49D4CCBA-5F2E-4C83-8B96-F0F1D03D9D22Q40397570-D4F9EC33-AA26-4680-A890-815D3C32DA1FQ40805504-AC597694-5322-42C3-B2DD-9395EB6FC3CCQ43830784-3BF59F4F-969C-42DD-8580-225AECCB5CF0Q47267316-3CE13B51-8F00-4C57-9495-D1D3307951B3Q54099126-FD3BBFCC-15E5-4AC2-A90C-3CB8EE573E35
P2860
Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Estimated incidence of cardiov ...... and a population-based survey.
@ast
Estimated incidence of cardiov ...... and a population-based survey.
@en
Estimated incidence of cardiov ...... and a population-based survey.
@nl
type
label
Estimated incidence of cardiov ...... and a population-based survey.
@ast
Estimated incidence of cardiov ...... and a population-based survey.
@en
Estimated incidence of cardiov ...... and a population-based survey.
@nl
prefLabel
Estimated incidence of cardiov ...... and a population-based survey.
@ast
Estimated incidence of cardiov ...... and a population-based survey.
@en
Estimated incidence of cardiov ...... and a population-based survey.
@nl
P2093
P2860
P356
P1476
Estimated incidence of cardiov ...... and a population-based survey
@en
P2093
Carlos A Aguilar-Salinas
Mauricio Hernández-Ávila
Nancy Reynoso-Noverón
Roopa Mehta
Rosalba Rojas-Martinez
P2860
P2888
P356
10.1186/1475-2840-10-1
P407
P577
2011-01-07T00:00:00Z
P5875
P6179
1040518636